PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

By: Investing.com

Aug 21 2024
9
325 Views

PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

Toronto, Ontario--(Newsfile Corp. - August 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, devel… [+8899 chars]

Pharmacide; Killing Us Softly

PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

Critical supply chain to save lives of very ill children designed and run from Ireland

How much caffeine is too much?

Sudan opening Adre border crossing to provide humanitarian lifeline

Honey Market Size Worth $20.65 Billion by 2033 - Rising Demand for Sugar & Artificial Sweeteners

Baba Ramdev criticises 'toxic' allopathy medicines that 'killed' millions of Indians

'Toxic' allopathic medicines have killed millions in India: Ramdev

New AI tool captures how proteins behave in context

When I use a word . . . Fictional drugs and the benefit to harm balance

Best Curcumin Supplements And Their Impact On Health: Benefits You Should Know

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine

Related